Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases
Diseases caused by chronic inflammation (e.g., arthritis, multiple sclerosis and diabetic ulcers) are multicausal, thus making treatment difficult and inefficient. Due to the age-associated nature of most of these disorders and the demographic transition towards an overall older population, efficien...
Main Authors: | Theo Thepen, Dmitrij Hristodorov, Radoslav Mladenov, Michael Huhn, Stefan Barth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/4/9/676 |
Similar Items
-
Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages
by: Theo Thepen, et al.
Published: (2013-01-01) -
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases
by: Olusiji A. Akinrinmade, et al.
Published: (2017-09-01) -
Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases
by: Nina Berges, et al.
Published: (2014-02-01) -
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
by: Letizia Polito, et al.
Published: (2017-05-01) -
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer Therapy
by: Michael Dieffenbach, et al.
Published: (2020-06-01)